Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,518 papers from all fields of science
Search
Sign In
Create Free Account
AG 1343
Known as:
AG-1343
, AG1343
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Nelfinavir
Nelfinavir Mesylate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Protease inhibitors
2005
Corpus ID: 34900645
1995
1995
Agouron protease inhibitor AG1343: activity reported.
James Js
1995
Corpus ID: 88765933
: Early study results show that the protease inhibitor AG1343, being developed by Agouron Pharmaceuticals of La Jolla, California…
Expand
1995
1995
Clinical potential of a new HIV protease inhibitor.
S. Chapman
,
J. Peterkin
,
B. Quart
,
M. Youle
Journal of the International Association of…
1995
Corpus ID: 7379273
Based on favorable results from a phase I study of AG1343 using oral doses of 800 mg and 400 mg, a new study assessed a 300 mg…
Expand
1995
1995
Protease inhibitor trials moving to next phase.
AIDS Alert
1995
Corpus ID: 23248415
Hoffmann-La Roche and Agouron Pharmaceuticals are establishing large clinical studies in the United States of their protease…
Expand
1995
1995
The next wave of protease inhibitors.
T. Smart
GMHC treatment issues : the Gay Men's Health…
1995
Corpus ID: 46581755
Three new protease inhibitors stand out in light of cross-resistance, either because they achieve levels in the blood that may…
Expand
1995
1995
International Congress on Chemotherapy.
T. Smart
GMHC treatment issues : the Gay Men's Health…
1995
Corpus ID: 32791371
Presentation highlights are provided from the Nineteenth International Congress on Chemotherapy in Montreal. Some of the new…
Expand
1995
1995
Ongoing protease inhibitor trials.
GMHC treatment issues : the Gay Men's Health…
1995
Corpus ID: 35633865
There are several ongoing protease inhibitor trials for individuals with HIV. Hoffmann-LaRoche's trial of saquinavir is a phase…
Expand
1995
1995
Phase I trial for AG1343.
Aids Patient Care
1995
Corpus ID: 5053110
1995
1995
Agouron protease inhibitor AG1343: activity reported.
J. James
AIDS treatment news
1995
Corpus ID: 1696164
Early study results show that the protease inhibitor AG1343, being developed by Agouron Pharmaceuticals of La Jolla, California…
Expand
1995
1995
Protease inhibitors.
J. T. Schouten
STEP perspective
1995
Corpus ID: 266277679
Protease inhibitors (PRIs) are a diverse group of drugs which block an HIV-1 enzyme needed for the production of new viruses…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE